Who owns AILERON THERAPEUTICS INC?
- Ticker: RNTX
- CUSIP Number: 00887a204
Tip: Access positions for across all investors
Analyze quarterly positions in Aileron Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aileron Therapeutics stock
Who bought or sold AILERON THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Voss Capital | 4.2M | $4.9M | 59% | Dec 2025 |
|
| BIOS Capital Management | 2.0M | $2.6M | 17% | Mar 2026 |
|
| Vanguard Group | 1.2M | $1.4M | 0% | Dec 2025 |
|
| Vanguard Capital Management | 999k | $1.3M | 100% | Mar 2026 |
|
| University of Texas Investment Management Company | 512k | $665k | 0% | Mar 2026 |
|
| Prosight Management | 443k | $513k | -22% | Dec 2025 |
|
| Cable Car Capital | 420k | $546k | 0% | Mar 2026 |
|
| Sigma Planning | 349k | $453k | 41% | Mar 2026 |
|
| Geode Capital Management | 345k | $448k | 21% | Mar 2026 |
|
| Texas Capital Bank Wealth Management Services | 274k | $356k | 4% | Mar 2026 |
|
| Gagnon Securities | 240k | $311k | 0% | Mar 2026 |
|
| Rima Management | 231k | $268k | 0% | Dec 2025 |
|
| Vanguard Fiduciary Trust | 155k | $201k | 100% | Mar 2026 |
|
| Rock Creek Group | 125k | $163k | 25% | Mar 2026 |
|
| ABS Direct Equity Fund | 125k | $163k | 0% | Mar 2026 |
|
| State Street Corporation | 76k | $88k | 374% | Dec 2025 |
|
| BlackRock | 69k | $89k | 25% | Mar 2026 |
|
| Susquehanna International | 59k | $68k | 91% | Dec 2025 |
|
| Northwestern Mutual Wealth Management Company | 42k | $55k | 0% | Mar 2026 |
|
| Chicago Partners Investment | 41k | $77k | 32% | Mar 2026 |
|
| Northern Trust | 41k | $47k | 57% | Dec 2025 |
|
| Mercer Global Advisors | 36k | $46k | 97% | Mar 2026 |
|
| Two Sigma Securities | 32k | $41k | 84% | Mar 2026 |
|
| Burns Wealth Management | 31k | $40k | 100% | Mar 2026 |
|
| Meridian Wealth Advisors | 29k | $37k | 0% | Mar 2026 |
|
| Americana Partners | 27k | $36k | 58% | Mar 2026 |
|
| Renaissance Technologies | 23k | $26k | 24% | Dec 2025 |
|
| Gleason Group | 22k | $29k | 0% | Mar 2026 |
|
| Sanders Morris Harris | 20k | $26k | 100% | Mar 2026 |
|
| Ancora Advisors | 20k | $26k | 0% | Mar 2026 |
|
| Global Retirement Partners | 19k | $22k | 168% | Dec 2025 |
|
| Cane Capital Partners | 18k | $23k | 100% | Mar 2026 |
|
| Hrt Financial | 16k | $20k | -53% | Mar 2026 |
|
| Annandale Capital | 15k | $20k | 0% | Mar 2026 |
|
| Virtu Financial | 14k | $16k | 100% | Dec 2025 |
|
| Steel Peak Wealth Management | 13k | $17k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 13k | $17k | 100% | Mar 2026 |
|
| HighTower Advisors | 10k | $13k | 0% | Mar 2026 |
|
| Rockefeller Capital Management | 5.1k | $6.6k | 0% | Mar 2026 |
|
| New Millennium Group | 2.0k | $2.4k | 100% | Dec 2025 |
|
| Tower Research Capital | 2.0k | $2.3k | -61% | Dec 2025 |
|
| JFS Wealth Advisors | 1.6k | $2.1k | 0% | Mar 2026 |
|
| Us Bancorp | 1.3k | $1.5k | 0% | Dec 2025 |
|
| UBS Group | 1.0k | $1.3k | -89% | Mar 2026 |
|
| Newbridge Financial Services Group | 97.00 | $126.003000 | 100% | Mar 2026 |
|
| Advisor Group Holdings | 70.00 | $80.997000 | 100% | Dec 2025 |
|
| Motiv8 Investments | 25.00 | $0 | 100% | Dec 2025 |
|
| Ronald Blue Trust | 20.00 | $26.000000 | 0% | Mar 2026 |
|
| Wells Fargo & Company | 20.00 | $26.000000 | 100% | Mar 2026 |
|
| Acadian Asset Management | 17.00 | $0 | 0% | Mar 2026 |
|
| Caitong International Asset Management | 3.00 | $3.999900 | 100% | Mar 2026 |
|
Who sold out of Aileron Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Dec 2025 | 120k | $139k |
| Jane Street | Dec 2025 | 62k | $72k |
| Two Sigma Investments | Dec 2025 | 42k | $48k |
| KG&L Capital Management | Dec 2025 | 18k | $21k |
| XTX Topco | Sep 2025 | 15k | $17k |
| Cetera Investment Advisers | Dec 2025 | 12k | $14k |